SBIO

ETFNYSEARCA 已收盘

ALPS Medical Breakthroughs ETF

North America官网 ↗
65.58 USD
+0.17+3.23%
盘后 63.46 -0.10%
2026-08-03
市值
规模 AUM
$201.62M
EPS
股息率
52 周区间
32.35 – 69.34
成交量
27.58K
Beta
0.74
目标价
52W 低 32.3552W 高 69.34
价格走势

公司简介

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.